Dr. Danielle Velez Leitner, MD
Claim this profileStudies Erectile Dysfunction
1 reported clinical trial
1 drug studied
More about Danielle Velez Leitner, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Danielle Velez Leitner, MD has experience with
- Low Intensity Shock Wave
Breakdown of trials Danielle Velez Leitner, MD has run
Erectile Dysfunction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Danielle Velez Leitner, MD specialize in?
Danielle Velez Leitner, MD focuses on Erectile Dysfunction and other conditions. In particular, much of their work with Erectile Dysfunction has involved treating patients, or patients who are undergoing treatment.
Is Danielle Velez Leitner, MD currently recruiting for clinical trials?
No, Danielle Velez Leitner, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Danielle Velez Leitner, MD has studied deeply?
Yes, Danielle Velez Leitner, MD has studied treatments such as Low intensity shock wave.
What is the best way to schedule an appointment with Danielle Velez Leitner, MD?
Apply for one of the trials that Danielle Velez Leitner, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.